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related to the severity of the calciﬁcation in the host tissues, nor with catheter manipulation during the
implant. A potential cause could be local ﬂow perturbations introduced by the implantation approach,
resulting in thrombo-embolic consequences. In particular, contrary to the surgical approach, TAVI pre-
serves the presence of the native leaﬂets, which are expanded in the paravalvular space inside the
Valsalva sinuses. The purpose of this study is to verify if this conﬁguration can determine hemodynamic
variations which may promote blood cell aggregation and thrombus formation.
Methods: The study was performed in vitro, on idealized models of the patient anatomy before and after
TAVI, reproducing a range of physiological operating conditions on a pulse duplicator. The ﬂuid dynamics
in the Valsalva sinuses was analyzed and characterized using phase resolved Particle Image Velocimetry.
Results: Comparison of the ﬂow downstream the valve clearly indicated major alterations in the ﬂuid
mechanics after TAVI, characterized by unphysiological conditions associated with extended stagnation
zones at the base of the sinuses.
Conclusion: The prolonged stasis observed in the Valsalva sinuses for the conﬁguration modelling the
presence of transcatheter aortic valves provides a ﬂuid dynamic environment favourable for red blood
cell aggregation and thrombus formation, which may justify some of the recently reported throm-
boembolic and ischemic events. This suggests the adoption of anticoagulation therapies following TAVI,
and some caution in the patients' selection.
& 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Aortic valve replacement is the deﬁnitive therapy for severe
aortic stenosis (Bach et al., 2009), and is normally performed by
open-heart surgical procedure, with the removal of the native
valve and its replacement with a mechanical or a tissue valve.
Transcatheter aortic valve implantation (TAVI) has recently
emerged as a more suitable option for patients with severe
symptomatic aortic stenosis, who are considered unsuitable for
conventional surgery because of severe comorbidities, the princi-
pal risk factor being the age of patients. In this case, the valve
substitute is delivered through the endovascular system via one of
several access routes: transfemoral, transapical, subclavian and
direct aortic (Bleiziffer et al., 2013). Clinical follow-up has docu-
mented a marked reduction in rehospitalisation with transfemoralr Ltd. This is an open access article
).TAVI as compared with medical management and, in comparison
with surgery, a signiﬁcantly shorter length of stay and earlier
improvement in functional status (Reynolds et al., 2012; Smith
et al., 2011). Also, transcatheter valves are commonly characterized
by hydrodynamic performance, systolic pressure drop, equivalent
or superior to surgically implanted valves, due to the thinner
supporting frame and the absence of the sewing ring, which result
into larger oriﬁce areas (Smith et al., 2011; Webb and Cribier,
2010).
Conversely, TAVI is associated with new complications which
include recurrence of mild to moderate paravalvular leakage,
resulting in a less favourable late survival (Makkar et al., 2012);
higher risk of injuries to the atrioventricular conduction system
producing partial or complete heart blockage (Eltchaninoff et al.,
2011; Moat et al., 2011); and high incidence of procedural and sub-
acute ischemic events and subclinical leaﬂets thrombosis (Astarci
et al., 2011; Kahlert et al., 2010; Makkar et al., 2015; Rodés-Cabau
et al., 2010; Samim et al., 2015). Whilst the cause for the leakageunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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(Bagur et al., 2012; Lerakis et al., 2013), the reasons leading to
post-implant thrombo-embolic consequences are still unclear.
Nombela-Franco et al. (2012) reported that, in a large sample of
1061 patients, nearly half of 30-day ischemic events occurs after
the ﬁrst 24 h with rates of acute and sub-acute Cerebrovascular
Events (CEVs), being 2.7% and 2.4%, respectively. Similarly, a recent
review of TAVI studies/registries (including FRANCE II, PARTNER II,
The European Sentinel, Advance) indicates that 30 days CEVs occur
with 1.8–3.6% rates (Fanning et al., 2014). Recently, it has been
suggested that a potential cause for post-procedural ischemic
events occurring could be associated with local ﬂow alterations
(Colli et al., 2016; Ducci et al., 2013; Rodés-Cabau et al., 2013). This
paper presents a study aimed at verifying the hemodynamic var-
iations produced by the presence of the native aortic valve in the
paravalvular space, and its potential contribution to thrombosis
and subacute CEVs. The analysis is performed experimentally, on
an idealized model, by means of Particle Image Velocimetry (PIV),
and provides a qualitative and quantitative characterization of the
ﬂuid dynamics in the Valsalva sinus pre- and post-TAVI.2. Methods
2.1. Pulse duplicator and cardiac chambers
Physiological hemodynamic conditions were reproduced in vitro using a car-
diovascular pulse duplicator system (Vivitro Superpump System SP3891, Vivitro,
Victoria, Canada). This is a hydro-mechanical mock circulatory system based on the
Windkessel model, powered by a digitally controlled pump. The system includes
view ports to observe valve function and transducer sites to measure ﬂow and ﬂuid
pressure in all cardiac chambers.Fig. 1. Sketches of the most widely used TAVI devices and of the aortic root before and a
aortic root; d) aortic root with Edwards SAPIEN XT; e) aortic root with CoreValve.A mock aortic root was made by casting from a two-part, optically clear, solvent
free, low viscosity silicone elastomer (MED-6015, NuSil Technology, Carpinteria, CA,
USA). The design of the root was based on the geometry and dimensions provided
by Swanson and Clark (1974), Thubrikar (1990) and Reul et al. (1990), and had a
diameter at the sino-tubular junction equal to 29 mm. A mock aortic valve ﬁtting
the root, based on the shape and dimensions reported by Thubrikar (1990) for a
healthy human valve, was manufactured by dip coating, using a silicone dispersion
(MED10-6607, Nusil, Carpinteria, CA, USA), with an average thickness of about
300 mm. The assembly of the described root and valve was used to model an
idealized healthy physiological situation, and will be referred to as ‘reference
conﬁguration’ in the rest of this paper.
As previously described, the objective of this study was to investigate the
changes produced on the ﬂuid ﬂow by the presence of the native valve leaﬂets after
implantation of transcatheter aortic valves. Currently, there are two valve platforms
in widespread clinical use: the Edwards SAPIEN (Edwards Lifesciences Inc.), which
uses a balloon-expandable tubular frame made of cobalt-chromium alloy (stainless
steel in the ﬁrst versions), supporting three leaﬂets made from bovine pericardium
and a PET fabric coating to provide an annular seal (Fig. 1a); and the CoreValve
(Medtronic Inc.), which uses a self-expanding frame made of nickel–titanium alloy,
supporting three leaﬂets and a sealing skirt made from porcine pericardium
(Fig. 1b). A growing number of newer transcatheter valves are in clinical evaluation,
but in all cases the prosthesis is implanted inside the leaﬂets of the native diseased
valve (Fig. 1d and e), which are expanded by a tubular supporting frame and
constrained to stay in this conﬁguration, while the occluding function is provided
by three prosthetic ﬂexible membranes. In order to verify how TAVI alters the ﬂow
in a generalized case, a thin cylindrical transparent wall made of acetate, with
thickness equal to 300 mm, was positioned around the leaﬂets of the valve, starting
from their base and with a height equal to the length of the leaﬂet axial centreline.
This corresponds to the most idealized post-implant condition, with: a) prosthetic
leaﬂets identical to the ones of the reference native-like valve and implanted in the
same orthotopic position; b) native leaﬂets of about constant thickness, presenting
no calciﬁcation and expanded in a perfectly cylindrical fashion; and c) total absence
of paravalvular leakage. This condition allows isolating the effect of the ‘valve-in-
valve’ conﬁguration on the ﬂow, by avoiding any other spurious inﬂuence that
could potentially contribute to affect the local ﬂow dynamics (i.e. prosthetic and
patient speciﬁc contributions). In the rest of this paper, this testing set-up will be
referred to as ‘post-TAVI conﬁguration’.
Dimensions of the mock valve-root systems for the reference and post-TAVI
conﬁgurations are provided in Fig. 2a–c.fter implantation: a) Edwards SAPIEN XT; b) CoreValve ReValving System; c) native
epit rochoidpost TAVI
nat ive leaflets
operat ing
leaflets
Fig. 2. (a–c) Side and top view sketches of the mock valve-root systems, showing the main dimensions and the PIV measurement region; (d, e) Experimental set up.
Fig. 3. Typical diagram of the volumetric ﬂowrate per cycle showing the selected
time instants analysed with PIV (70 bpm and 4.5 l/min).
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characterised by three beat rates of 60, 70 and 80 bpm and three cardiac outputs of
3, 4.5 and 6 l/min. In order to reduce the mechanical load acting on the closed
valve, a mean systolic aortic pressure of 55 mmHg was used. Though this is lower
than the normotensive value, which is around 100 mmHg, it was veriﬁed that the
transvalvular systolic pressure differences and the ﬂowrates are not signiﬁcantly
affected by these hypotensive conditions.
2.2. Particle Image Velocimetry
Flow characterisation was performed using 2D Particle Image Velocimetry
(PIV). This is a non-intrusive optical technique, which provides measurements
of the instantaneous velocity vector ﬁeld in a plane located in the ﬂow region of
interest. The system employed in this study consisted of a continuous diode
laser of 300 mW and wavelength of 532 nm, a cylindrical lens to convert the
laser beam into a light sheet of approximately 1 mm thickness, and a high-
speed intensiﬁed camera. The PIV system was synchronised with the pump of
the pulse duplicator through a timing box, and the camera was triggered at
selected time instants of the cardiac cycle to collect pairs of images Δt ¼ 3 ms
apart. The experimental set up and measurement regions are provided in Fig. 2.
For a thorough characterization of the ﬂow dynamics of the cardiac cycle, 12
time instants were selected, as described in Fig. 3: points A, B and C during
valve opening; point D at the maximum valve opening; points E and F after
complete opening and before closing starts; points G, H and I during valve
closing; point J at the at ﬁrst instant after systole when the ﬂow becomes equal
to zero; and points K and L when the valve is closed. For each time instant phase
resolved averages were obtained from a sample of 500 instantaneous velocity
ﬁelds. Silver-coated hollow spherical particles of 10 mm average diameter and
1400 kg/m3 density were used, while the adaptive correlation algorithm built in
Dynamics Studio (Dantec Ltd.) with a 50% window overlap was employed to
obtain a ﬁnal resolution of 88 pixels (corresponding to 0.10.1 mm). To best
compare the phase resolved velocity ﬁelds associated with the different con-
ﬁgurations analysed, the local velocity magnitude, v, was normalised with a
reference velocity, vref, deﬁned as in Eq. (1):
vref ¼
Q
ASTJ
; ð1Þ
where Q is the volumetric ﬂowrate and ASTJ is the area of the cross section of the
aortic root at the sino-tubular junction. The normalised velocity, v*, is obtainedas in Eq. (2):
v ¼ v
vref
: ð2Þ
To visualise the ﬂow within the sinus and its variation for the reference and
post-TAVI conﬁgurations, contour and vector maps of the local velocity were cal-
culated for each instant investigated. A mask with white streamlines was sketched
in the zone above the aortic valve, where the local ﬂuid velocity is considerably
higher than that occurring in the Valsalva sinuses and could not be quantiﬁed with
the time intervalΔt selected in this study to characterise the region of interest. The
streamlines are solely reported in this work as a visual aid to qualitatively represent
the ﬂow in the fast ﬂow region closer to the valve exit, and are sketched based on
Fig. 4. (a–c) Visualisation of the degree of distortion induced by refraction mismatch at the sinus wall, for glycerol volume percentage of: a) 0%; b) 32 %; c) 37 %; and,
(d) variation of the correlation coefﬁcient, Rbw, and solution to blood viscosity ratio for increasing glycerol volume percentage.
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the cardiac cycle.
Phase resolved turbulence contour maps were determined based on the Rey-
nolds triple decomposition averages described in Reynolds and Hussain (1971).
2.3. Blood analogue liquid
A number of pure liquids and liquid solutions have been used in other
studies to simulate blood, including pure water (Falahatpisheh and Kheradvar,
2012; Van Steenhoven and Van Dongen, 1979; Wendt et al., 2012), saline
solution (Akutsu et al., 2008; Bottio et al., 2004; Ducci et al., 2013; Grigioni et
al., 2000) and a water–glycerol solution (Azadani et al., 2009; Bullen and
Rogers, 1968; Grigioni et al., 2003; Guivier-Curien et al., 2009; Kadem et al.,
2005, 2006; Lim et al., 1994, 1998; Stühle et al., 2011; Yoganathan et al., 1986).
When using a laser-based technique such as PIV, it is essential to minimise the
optical distortion due to the refraction occurring at the interface between dif-
ferent media in complex geometries. This has often been addressed by using
more complex solutions, such as water–glycerol–sodium iodide (Browne et al.,
2000; Leo et al., 2006), saline solution with glycerol (Balducci et al., 2004) and
distilled water with potassium iodide (Toninato et al., 2016).
For all described cases, the approximation of Newtonian behaviour is accepted,
neglecting the variation of dynamic viscosity which becomes signiﬁcant at levels of
shear rate inferior to 100 s1 (Chien, 1970; Fedosov et al., 2011; Kim et al., 2012).
In the present study, a clear colourless solution with same dynamic viscosity as
blood at 37 °C (mb ¼ 4 10–3 Pa s) and minimum refractive index mismatch with
the mock aortic root and valve's leaﬂets (n ¼ 1.40) was developed by adding gly-
cerol (37 vol%) to a solution of water and potassium iodide (24 wt%). To identify theoptimum volumetric ratio of the mixture, providing best blood viscosity and
refractive index matching, the correlation coefﬁcient, Rbw, was estimated according
to Eq. (3):
Rbw ¼
Id  I0
I0  I0
ð3Þ
This is based on the image projection of the distorted grid captured at the back
of the root-ﬂuid solution system, Id, on to an ideal grid corresponding to zero
distortion, I0. Three characteristic images visualising different degree of optical
distortion induced by the refraction at the sinus wall of the root are provided in
Fig. 4a–c, for increasing glycerol percentage. From Fig. 4d, it can be seen that the
solution provides minimum light distortion (maximum Rbw coefﬁcient) and
dynamic viscosity, μsol, similar to blood (μsol/μb E 1) for a glycerol volumetric ratio
of 37%.3. Results
The ﬂow ﬁelds obtained for each conﬁguration (reference and
post-TAVI) at the different beat and ﬂow rates were similar and pre-
sented identical features. This is evident in Fig. 5a–h, where char-
acteristic ﬂow ﬁelds associated to extreme cases (3–6 l/min, and 60–
80 bpm) at instants B and D in the cardiac cycle exhibit similar ﬂow
patterns and scaled velocity intensity, both in pre- and post-TAVI
conﬁgurations. Hence, for brevity, only the results corresponding to
Fig. 5. Flow ﬁelds of reference and post-TAVI conﬁgurations for different operating conditions at one representative instant of the opening phase (instant B) within the
cardiac cycle: reference conﬁguration at 60 bpm (a) and 4.5 l/min (b); reference conﬁguration at 80 bpm (c) and 4.5 l/min (d); post-TAVI conﬁguration at 60 bpm (e) and
4.5 l/min (f); post-TAVI conﬁguration at 80 bpm (g) and 4.5 l/min (h).
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discussed hereafter.
Fig. 6 presents the phase resolved velocity maps for these
intermediate conditions. At the beginning of the systole (instant
A), the ﬂow is directed radially next to the leaﬂet, then turns to
follow the Valsalva's sinus shape, aligning with the vertical axis in
the upper region, where the liquid leaves the aortic root. This ﬂow
pattern is qualitatively preserved for the entire opening phase,
with local velocity magnitudes increasing fourfold at instant B. At
instant C, after opening is complete, a vortex ring is formed at the
top of the valve leaﬂet (counter-clockwise in the ﬁgure). From
instant C to instant F this vortex moves radially towards the wall of
the aortic root, at the top of the Valsalva's sinus, maintaining its
direction of rotation and intensity. From instants G to H the ejec-
tion jet slows down, resulting in a reduction of the dimensionless
velocity. The vortex ring is still visible, but its intensity has reduced
signiﬁcantly. Hence the valve starts closing (instants H to J), sup-
ported by a ﬂow directed from the aortic root towards the leaﬂets.
At instants K and L the valve is fully closed and a counter-rotating
vortex (clockwise in the ﬁgure) develops and ﬁlls the entire sinus.
The corresponding phase-resolved magnitude and velocity
vector maps for the post-TAVI conﬁguration at same operating
conditions (70 bpm and 4.5 l/min) are provided in Fig. 7. Similarly
to the physiological/reference conﬁguration, at instant A the local
ﬂow direction is perpendicular to the leaﬂet in its proximity, and
axial in the upper portion of the root. At instant B, as the leaﬂet
moves towards its open position, a vortex ring forms at the exit ofthe cylindrical wall. The vortex remains in this region up to the
instant of maximum ﬂow (point F), but its intensity decreases as
the ﬂow velocity reduces (instants G to H). During valve closure, in
instants I and J, the local depression created by the leaﬂet move-
ment determines a ﬂuid suction from the upper part of the Val-
salva sinus, with ﬂuid moving around the edge of the cylinder
mimicking the presence of the native leaﬂets. This feature is still
preserved during early diastole, as evident at instants K and L.
Direct comparison of the velocity ﬁelds of Figs. 6 and 7 indi-
cates that the post-TAVI conﬁguration is associated with a sub-
stantial drop of ﬂow velocity inside the Valsalva sinus, resulting in
a zone of stagnation at the base of this region.
The described ﬂow dynamic observed for the reference and
post-TAVI conﬁgurations were consistently observed at all the
other ﬂow and heart beat rate examined, with no substantial
variations in the dimensionless velocity. Obviously, the dimen-
sional velocity increased proportionally with the ﬂow rate.
Analysis of the phase resolved turbulence levels in the Valsalva
sinus, described in Figs. 8 and 9, indicates that the reference
conﬁguration is associated with higher turbulence (0.15 vs. 0.10),
but for both conﬁgurations the velocity standard deviation never
exceed 0.2 m/s.
A comparison of the shear rate maps obtained in the Valsalva
sinus for the two conﬁgurations before and after TAVI is provided
in Fig. 10. Shear rate thresholds of 10 and 100 s1 were selected to
best visualize areas subject to high ( _γ4 100 s1), intermediate
(10 o _γo 100 s1) and low ( _γo 10 s1) shear, and to identify
Fig. 6. Phase resolved velocity contour map and vector ﬁelds for the reference conﬁguration at different time instants throughout the cardiac cycle, for the representative
intermediate operating conditions (70 bpm and 4.5 l/min).
Fig. 7. Phase resolved velocity contour map and vector ﬁelds for the post-TAVI conﬁguration at different time instants throughout the cardiac cycle, for the representative
intermediate operating conditions (70 bpm and 4.5 l/min).
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Fig. 8. Phase resolved turbulence contour map and vector ﬁelds for the reference conﬁguration at different time instants throughout the cardiac cycle, for the representative
intermediate operating conditions (70 bpm and 4.5 l/min).
Fig. 9. Phase resolved turbulence contour map and vector ﬁelds for the post-TAVI conﬁguration at different time instants throughout the cardiac cycle, for the representative
intermediate operating conditions (70 bpm and 4.5 l/min).
A. Ducci et al. / Journal of Biomechanics 49 (2016) 4080–40894086regions where Newtonian ﬂuid assumption is valid (green
threshold). In the post-TAVI conﬁguration, the value of shear rate
in the Valsalva sinus is lower than 10 s1 over an extended regionduring the entire cardiac cycle. On the contrary, though regions of
low shear rate are present during diastole also in the reference
conﬁguration, the sinus is periodically washed at each cardiac
Fig. 10. Visualisation of the ﬂow regions subject to different degree of shear rate: (red) low shear rate, (cyan) intermediate shear rate, (green) high shear rate. Results for the
reference and post-TAVI conﬁgurations are represented on the top and on the bottom row, respectively. (For interpretation of the references to colour in this ﬁgure legend,
the reader is referred to the web version of this article.)
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cell aggregation (Kaliviotis and Yianneskis, 2008).
These dynamics are preserved for all the different combina-
tions of beat rate and ﬂow rate investigated, without signiﬁcant
variation of the velocity ﬁeld, turbulence and shear rate.4. Discussion
Comparison of the ﬂow downstream the valve before and
after TAVI clearly indicates major variations in the ﬂuid
mechanics and operating mechanisms of the valve. For the
reference conﬁguration, in the early stages of the opening the
ﬂuid runs along the Valsalva sinus wall with signiﬁcant radial and
axial velocity components. This motion supports the leaﬂet
movement towards the open conﬁguration. During this stage, a
vortex ring forms at the edge of the valve's leaﬂet, and moves to
the top of the Valsalva's sinus. The vortex stays in this position for
the whole duration of the ejection phase and disappears when
the leaﬂet moves to the closed position. When the valve is fully
closed, a counter-vortex forms closed to the leaﬂet, and expands
to the center of Valsalva's sinus.
In the case of the post-TAVI conﬁguration, the ﬂuid dynamics
in the Valsalva sinus results substantially different. During
opening, the leaﬂet of the native valve acts as a cylindrical wall,
forcing an axial ﬂow. As in the previous case, a vortex ring formsat the valve exit, at the top of the Valsalva sinus. However, this
appears to be associated to the rigid native leaﬂets edge, rather
than the operating prosthetic leaﬂets, and maintains its position
for the whole duration of the ejection phase. The vortex dis-
appears when the prosthetic leaﬂets move to the closed position.
During closing, the liquid comes back to the leaﬂet in the axial
direction, without producing the vortical structures observed for
the native conﬁguration. Between the sinus and the native leaﬂet
partition develops an extended and prolonged stagnation zone
with minimum shear rate (below 100 s1), which is present
during the full cycle. For a non-Newtonian ﬂuid with the rheo-
logical behavior typical of human blood, this permanent level of
shear rate leads to a substantial increase in the dynamic viscosity
(Chien, 1970; Fedosov et al., 2011; Kaliviotis and Yianneskis, 2011;
Kim et al., 2012). Hence, the prolonged stasis observed in the
Valsalva sinus for the post-TAVI conﬁguration is likely to be more
severe in the in vivo condition, favouring red blood cell aggre-
gation and thrombus formation.
This may justify some of the ischaemic complications reported
after transcatheter heart valve implantation. In particular, though
major strokes with permanent deﬁcit are rare and have similar
rate between TAVI and surgical replacements, as shown from
studies at 30 days (Miller et al., 2012) and 2 years (Kodali et al.,
2012), transcatheter approaches are associated with much higher
rate of new post-procedural cerebral lesions, which are reported
to affect up to 90% of treated patients (Astarci et al., 2011; Kahlert
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detected ischemic events are normally asymptomatic, but can be
associated with unnoticed deﬁcits in physical and cognitive
functions, raising considerably the risk of successive stroke and
dementia (Vermeer et al., 2007). There is no evidence that these
embolic complication can directly be associated to the severity of
the calciﬁcation present in the host tissues, as there is no sig-
niﬁcant correlation with the number and volume of the ischemic
lesions (Rodés-Cabau et al., 2010; Samim et al., 2015). Also,
catheter manipulation in the blood vessels or retrograde crossing
of the aortic valve during the valve implantation does not appear
to be a major cause for the lesions, as the incidence of embolic
events is similar with the transfemoral approach, which reaches
the aortic valve from the femoral artery, after crossing of the
entire aorta, and the transapical access, which directly reaches
the valve from the inﬂow, after puncturing the apex of the left
ventricle (Astarci et al., 2011; Athappan et al., 2014; Rodés-Cabau
et al., 2010).
This study shows that the presence of transcatheter aortic
valves produces unphysiological ﬂows in the aortic root that result
into stagnation at the base of the Valsalva sinuses, supporting the
hypothesis that the presence of the native aortic valve in the
paravalvular space might promote blood stasis, which is a main
contributing factor towards thrombosis and thromboembolic
events (Ducci et al., 2013; Rodés-Cabau et al., 2013). This might
also be reﬂected in some of the observed cases of post-TAVI
thrombosis (De Marchena et al., 2015), which may be respon-
sible for the higher incidence of reduced leaﬂet motion, recently
reported by Makkar et al. (2015).
The ﬁndings from this study, which can provide some justiﬁ-
cation to the emerging clinical evidence, suggest the adoption of
chronic anticoagulation therapies following TAVI, and recommend
some caution when selecting this valve therapy for patients
unsuitable for anticoagulant medications.
Of course, the interpretation of the present results has to take
into consideration a number of assumptions, idealizations and
limitations that were introduced in the experiments. Firstly, due
to the attempt to obtain generalizable ﬁndings, the root and
leaﬂets were based on idealized geometries, which do not con-
sider patient speciﬁc irregularities. Moreover, they do not
account for the coronary ﬂow and the compliance of the aortic
root. Though these factors are likely to reduce the blood stasis,
the study can still be considered representative of the most
common case in TAVI patients, where the aortic root is severely
calciﬁed, and indicative of the ﬂow conditions in the posterior
aortic sinus (non-coronary sinus), where the stagnation is
expected to be more severe. Another approximation of the study
is in the use of a Newtonian ﬂuid, that does not model accurately
the increase in viscosity occurring at low levels of shear stress,
associated with the red cells aggregation. Finally, the PIV system
set up was optimized to capture the slow ﬂow motion occurring
in the Valsalva sinus, and therefore could not resolve the fast ﬂow
regions occurring during systole.5. Conclusions
This study presents a detailed analysis of the ﬂuid dynamics
inside the Valsalva sinus under ideal conditions before and after
TAVI, identifying and quantifying the ﬂow variation produced by
the treatment. Quantiﬁcation of relevant ﬂow parameters was
provided by means of phase resolved PIV measurements for a
range of beat rates and cardiac outputs at selected time instants of
the cardiac cycle.
The analysis of the ﬂow downstream of the valve indicated that
the ﬂuid dynamics that occurs in physiological conditions into theValsalva sinuses, and supports the opening and closing mechan-
isms, is largely altered when a TAVI device is implanted. In parti-
cular, a reduction of turbulence, velocity magnitude and shear rate
is observed between the leaﬂets of the native valve and the aortic
wall. This is associated with an extended stagnation zone at the
base of the sinus, providing a ﬂuid dynamic environment that may
promote thrombotic phenomena and contribute to thromboem-
bolic and ischaemic events.Conﬂict of interest
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